On Monday, Matthew Ryan Cole, CEO of Strive Inc., purchased 515,195 shares of ASST at $0.81 each, totaling approximately $415,999. At the high point of trading on Tuesday, ASST climbed to $0.89, representing a 10.8% gain for Cole, while Strive Inc. saw an overall increase of about 9.8% for the day.
Additionally, Patrick G. Enright from Vera Therapeutics bought 5,882 shares at $42.50 each on Thursday, amounting to $249,985. This follows a previous investment where Enright acquired 5.28 million shares at $21.11 each in the last twelve months. Despite a slight decrease of approximately 1% in Vera Therapeutics’ stock on Tuesday, Enright’s purchase was up about 17.1% at the session’s peak, with shares reaching $49.77.
